We've detected an Ad Blocker in your browser.
Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.
A TMA initiative in partnership with Radcliffe Cardiology
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology are delighted to introduce e-SPACE Heart Failure 2022 to be held 14–15 October.
e-SPACE Heart Failure 2022 will deliver best-in-class free-to-access virtual education. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 will both optimise geographical reach whilst delivering both global and regional insight.
A thoughtfully curated programme will support the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice, as well as aiding the discovery of the latest information on patient profiling in heart failure for tailoring medical therapy.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) will lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
This year’s e-SPACE Heart Failure will, for the first time, bring together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Underpinned by this combined expertise in educational content and delivery, and led by an international faculty of global standing, e-SPACE Heart Failure 2022 promises to be the widest reaching and most engaging to date.
REGISTER FREE NOW
REGISTER NOW
Register Now
CHAIR
Charité Campus Virchow-Klinikum, Berlin, DE
Prof Stefan Anker studied medicine at Charité Medical School of Humboldt-University Berlin, Germany from 1987 to 1993. He went on to complete his PhD at the National Heart and Lung Institute of Imperial College London, United Kingdom, in 1998. Since then, he has had teaching appointments in several countries including the UK, Germany, Australia and Italy.
He has worked as a Junior Professor and then as Professor for Charité Campus Virchow-Klinikum since 2002. He is a member of and serves on the Boards of several academic organizations, including the Board of the Heart Failure Association of the European Society of Cardiology and the Editorial Board of the Journal of Cachexia, Sarcopenia and Muscle (SCWD). He is also a member of the German Centre for Cardiovascular Research (DZHK).
More info
Less info
CO-CHAIR
Baylor Scott and White Research Institute, Texas, US
Dr Javed Butler is Professor and Chair of the Department of Medicine at University of Mississippi Medical Center in Jackson Mississippi, and also Patrick H Lehan Chair of Cardiovascular Research. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure. He has authored more than 900 peer-reviewed publications. Previously, he was Director of the Division of Cardiovascular Medicine and Co-director of the Heart Institute at State University of New York (SUNY) Stony Brook University.
More info
Less info
CHAIR
University of Warwick, Coventry, UK
Prof Andrew Coats is President of the Heart Failure Association and Professor of Cardiology, University of Warwick, Coventry, UK. He is an Australian-British academic cardiologist and inventor with a main interest of heart failure.
From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine of the University of Sydney. Prof Coats is Editor-in-Chief of the Cardiac Failure Review editorial board.
More info
Less info
CHAIR
University of Manitoba, Manitoba, CA
Dr Shelley Zieroth is at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada. Dr Zieroth attended medical school at the University of Manitoba, where she went on to train in internal medicine and cardiology. She completed her postdoctoral clinical fellowship, specializing in advanced heart failure and cardiac transplant, at Toronto General Hospital. She has lectured internationally on the subject of heart failure. Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
More info
Less info
Kasr Al-Ainy School of Medicine, Cairo, EG
Ohio State University College of Medicine. Ohio, US
University of Brescia, Brescia, IT
S.S Heart Care Centre, Uttar Pradesh, IN
Royal Brisbane and Women’s Hospital, Brisbane, AU
INECO Neurociencias Oroño, Santa Fe, AR
University of Chicago Medicine, Illinois, US
Hannover Medical School, Hannover, DE
Hospital Germans Trias i Pujol, Barcelona, ES
Baylor College of Medicine, Texas, US
Erasmus University Medical Centre, Rotterdam, NL
St George's University of London, London, UK
IRCCS MultiMedica, Milan, IT
University of Medicine Carol Davila, Bucharest, RO
Max Super Specialty Hospital, New Delhi, IN
University of Glasgow, Glasgow, UK
University of A Coruña, A Coruña, ES
University of Glasgow, Glasgow, UK
University of Alberta, Alberta, CA
National and Kapodistrian University of Athens, Athens, GR
Duke University, North Carolina, US
San Raffaele Research Hospital, Milan, IT
Duke University School of Medicine, North Carolina, US
Sree Chitra Institute, Trivandrum, IN
Wrocław Medical University, Wrocław, PL
St George’s Hospital, London, UK
National Heart Centre Singapore, SG
Medical College of Wisconsin, Wisconsin, US
Charité Campus Mitte, Berlin, DE
University of Ljubljana, Ljubljana, SI
Semmelweis University Heart and Vascular Center, Budapest, HU
Emory University School of Medicine, Georgia, US
Baylor University Medical Center, Texas, US
University of Texas Southwestern Medical Center, Texas, US
Rabin Medical Center, Petah Tikva, IL
University of Glasgow, Glasgow, UK
Wayne State University, Michigan, US
Wrocław Medical University, Wrocław, PL
Mayo Clinic, Minnesota, US
St George's University of London, London, UK
Cardiovascular Clinic Santa Maria, Medellin, CO
University of Glasgow, Glasgow, UK
Karolinska Institute, Stockholm, SE
Belgrade University, Belgrade, RS
King George's Medical University, Uttar Pradesh, IN
Saifee Hospital, Mumbai, IN
CardioVascular Center Frankfurt, Frankfurt, DE
Hopital Bichat, Paris, FR
Icahn School of Medicine at Mount Sinai, New York, US
San Francisco Veterans Affairs Medical Center, California, US
Institute for Molecular and Translational Therapeutic Strategies, Hannover, DE
Kyushu University, Fukuoka, JP
University of Washington, Washington, US
Brigham and Women’s Hospital, Massachusetts, US
McMaster University, Hamilton, CA
St. Michael's Hospital, Toronto, CA
University Medical Center of Mainz, Mainz, DE
University Medicine Göttingen, Göttingen, DE
Dokuz Eylul University, Izmir, TR
Academic Hospital (CHU), Nancy, FR
Fuwai Hospital, Beijing, CN
Register now
(Please note this programme is subject to change)
If you’re interested in becoming an educational partner or sponsor at this event, please contact sales@radcliffe-group.com
Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.
Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.
For more information on TMA, please visit www.tmacademy.org.
We are Radcliffe, a knowledge network for the cardiovascular community.
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles: